UBS raised the firm’s price target on Ovintiv (OVV) to $61 from $58 and keeps a Buy rating on the shares. The firm updated its model following the Q4 earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv price target lowered to $43 from $47 at Evercore ISI
- Ovintiv: High-Quality Core Assets, Strengthening Balance Sheet, and Robust Free Cash Flow Support Overweight Rating and $58 Target
- Ovintiv resumed with an Overweight at JPMorgan
- Ovintiv price target raised to $58 from $55 at Barclays
- Ovintiv price target raised to $50 from $42 at Roth Capital